JPRN-UMIN000022129
Completed
未知
The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test) - Propagermanium test
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Osaka University Hospital
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Patients with active double cancer.(2\)Patients with serious drug hypersensitivity or with a history of drug allergy.(3\)Patients with serious complications.(4\)Patients with jaundice,cirrhosis or with suspected cirrhosis of the liver.(5\)There is a history of chronic hepatitis B, and in the present study drug has already been ingested.(6\)Patients with active infection.(7\)Women who have a possibility of or in the pregnancy,who hope to become pregnant,or who are breast\-feeding. Men who wish to become pregnant partner.(8\)Patients with severe mental disorder.(9Other patients whom the physician decided to be unsuitable for safely carrying out the present study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
This study will investigate the anticancer effect and treatment-related safety when focused ultrasound stimuli is given for the pancreatic cancer in patients with unresectable pancreatic cancer who need chemotherapy in a prospective mannerNeoplasmsKCT0006302Seoul National University Hospital60
Recruiting
Not Applicable
Clinical trials for the safety and efficacy of the combination of XELOX,the colorectal cancer radical resection adjuvant chemotherapy and of chronic hepatitis therapeutic agent 3 oxygelmillpropionic acid polymer.(Phase 1 test)Colorectal cancerJPRN-UMIN000022440Osaka University Hospital5
Recruiting
Phase 2
A clinical study to evaluate the comparative efficacy of three Unani drugs in the treatment of Hepatitis B carriersCTRI/2018/06/014642DG Central Council for Research in Unani Medicine
Completed
Phase 2
A study investigating the efficacy and safety of CNS prophylaxis with R-CHOP and high-dose methotrexate in patients with de novo diffuse large B-cell lymphoma who have high risk for CNS relapse.Diffuse large B-cell lymphomaJPRN-UMIN000013540Department of Hematology and Oncology, Osaka University Graduate School of Medicine100
Completed
Not Applicable
Clinical trial for efficacy and safety related to weekly dosage regimens of methotrexateJPRN-UMIN000021157Yokohama Minami Kyousai Hospital120